Notably, chromosome 3 allelic loss and promoter hypermethylation are considered the main causes of Sema3B downregulation, and Sema3B reduced expresson was detected at mRNA and protein levels in ESCC tumor specimens 60. Here, SEMA3B is linked to neoplasm.